0.4900EUR-4.48%Mkt Cap: 38.62M $P/E: —1d ago
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmenta…
Industry Peers
Medical Devices$198.81BUSDP/E 36.9
$120.66BUSDP/E 34.7
$125.70BUSDP/E 33.9
$111.66BUSDP/E 24.9
$75.37BUSDP/E 21.1
$53.13BUSDP/E 54.9
$48.43BUSDP/E 19.9
$33.94BUSDP/E 17.2
$33.92BUSDP/E 35.5
$25.21BUSDP/E 20.8
$19.21BUSDP/E 24.5
$16.48BUSDP/E 26.9
$12.87BUSDP/E 80.5
$11.52BUSDP/E 19.9
$11.86BUSDP/E 22.6
$11.18BUSD
$9.89BUSDP/E 16.8
$10.51BUSDP/E 28.4
$9.75BUSDP/E 44.3
MASI
Masimo Corporation$9.42BUSDP/E 44.4
| Headline | Source | Time |
|---|---|---|
Older | ||
 Two out of five workers could go at diagnostics firm Novacyt in restructuring The molecular diagnostics company, which is listed on London’s junior AIM market, launched a consultation process on Monday. | PPA Media: Money | |
LLe Revenu | ||